148 related articles for article (PubMed ID: 22424607)
1. Discrete choice experiment produced estimates of acceptable risks of therapeutic options in cancer patients with febrile neutropenia.
Sung L; Alibhai SM; Ethier MC; Teuffel O; Cheng S; Fisman D; Regier DA
J Clin Epidemiol; 2012 Jun; 65(6):627-34. PubMed ID: 22424607
[TBL] [Abstract][Full Text] [Related]
2. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
4. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
[TBL] [Abstract][Full Text] [Related]
5. Advances in management of low-risk febrile neutropenia.
Teuffel O; Sung L
Curr Opin Pediatr; 2012 Feb; 24(1):40-5. PubMed ID: 22037219
[TBL] [Abstract][Full Text] [Related]
6. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
[TBL] [Abstract][Full Text] [Related]
7. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
8. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
Aquino VM; Herrera L; Sandler ES; Buchanan GR
Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
[TBL] [Abstract][Full Text] [Related]
10. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
11. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
Chamilos G; Bamias A; Efstathiou E; Zorzou PM; Kastritis E; Kostis E; Papadimitriou C; Dimopoulos MA
Cancer; 2005 Jun; 103(12):2629-35. PubMed ID: 15856427
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
[TBL] [Abstract][Full Text] [Related]
13. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
15. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
[TBL] [Abstract][Full Text] [Related]
16. [Criteria of low risk of mortality in children with neutropenia and fever during cancer chemotherapy].
Paganini HR; Rodríguez Brieshcke T; Zubizarreta P; Latella A; Firpo V; Fernandez C; Armada A; Casimir L; Debbag R
Medicina (B Aires); 2001; 61(1):63-6. PubMed ID: 11265626
[TBL] [Abstract][Full Text] [Related]
17. Evolving concepts of management of febrile neutropenia in children with cancer.
Orudjev E; Lange BJ
Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
[TBL] [Abstract][Full Text] [Related]
18. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
Cooper MR; Durand CR; Beaulac MT; Steinberg M
Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
[TBL] [Abstract][Full Text] [Related]
19. Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.
Rolston KV; Manzullo EF; Elting LS; Frisbee-Hume SE; McMahon L; Theriault RL; Patel S; Benjamin RS
Cancer; 2006 Jun; 106(11):2489-94. PubMed ID: 16628654
[TBL] [Abstract][Full Text] [Related]
20. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
Rubenstein EB; Rolston KV; Kim YJ
N Engl J Med; 2000 Jan; 342(1):56; author reply 56-8. PubMed ID: 10627211
[No Abstract] [Full Text] [Related]
[Next] [New Search]